Close Menu

NEW YORK – With flu season approaching, Finland's Abacus Diagnostica has decided to roll out a multiplex RT-PCR test for SARS-CoV-2, influenza A and B, and respiratory syncytial virus. The assay should have a CE-IVD mark by November and will serve the molecular diagnostics firm's growing European client base, according to CEO Erno Sundberg.

"This is a good fit for labs that are worried about running out of testing capacity when flu season hits," he said.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.